Cargando…
Atomoxetine: a novel treatment for child and adult ADHD
Attention deficit hyperactivity disorder (ADHD) is a common chronic condition with childhood onset that can continue into adulthood. Medication is a fundamental element in the management of this disorder. Atomoxetine is the newest nonstimulant medication approved by the United States Food and Drug A...
Autor principal: | Ledbetter, Marcialee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671957/ https://www.ncbi.nlm.nih.gov/pubmed/19412494 |
Ejemplares similares
-
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
por: Hammerness, Paul, et al.
Publicado: (2009) -
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
por: Domnitei, Diana, et al.
Publicado: (2010) -
Once-daily treatment of ADHD with guanfacine: patient implications
por: Strange, Brandon C
Publicado: (2008) -
Minor pulmonary malformations in a child
por: Manti, Sara, et al.
Publicado: (2018) -
Novel therapies for severe asthma in children and adults
por: Delimpoura, Vasiliki, et al.
Publicado: (2018)